SSE 50 (Shanghai)

Zhangzhou Pientzehuang Pharmaceutical

The exclusive maker of Pien Tze Huang, a prized traditional Chinese medicine known for liver protection and anti-inflammatory use. SSE 50 (Shanghai) constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.

600436.SS Updated Jul 11, 2026 2 AI consumers· 1 recurring

Annual return · 2026-07-10'21+19.9%'22-12.7%'23-35.6%'24+3.1%'25-19.5%YTD-27%
Money in·
Zhangzhou Pientzehuang Pharmaceuticalapprox. CN¥10.0B
Money out·

Financials & Segments

  • Total revenue · approx. CN¥10.0B (FY2023)
  • Segments · Liver medicine (Pientzehuang) · Cosmetics & health foods · Pharmaceutical distribution

Revenue from

No refined links yet.

Pays to

No refined links yet.


← All companiesMarkdown · JSON

For information only, not investment advice. Content on this site is generated by AI from verified, cross-checked sources and may contain errors.

© 2026 Willow Investments, Inc.Company value-chain data · contact@willowinvt.com